News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

New clinical trials at JFK Brain Tumor Center in Edison, NJ

Al's Comment:

 I usually do not list trials at an individual brain tumor center, but this one is special. These are 4 of my favorite  trials, all done at one medical center, and they are also certified to use the Optune treatment as well.  For more information, look at virtualtrials.com  click on LEARN ABOUT then Tocagen, then Learn About and Vaccines.


Posted on: 03/15/2015

 

These trials are now being offered at JFK Brain Tumor Center in Edison, NJ.  

 

A Phase 1 Trial of ICT121 (brain tumor vaccine) in the treatment of first recurrent glioblastoma. *This trial requires gross total resection or near total with less than one cubic centimeter of residual disease. Patient's need to be HLAA2 positive, which will be tested at screening.

 

A Phase 1 Ascending Dose Trial of the Safety and Tolerability of Toca 511, a Retroviral Replicating Vector, Administered to Subjects at the Time of Resection for Recurrent High Grade Glioma and Followed by Treatment with Toca FC, Extended Release 5FC.

       

A Phase 1 Ascending Dose Trial of the Safety and Tolerability of Toca 511, a Retroviral Replicating Vector, Administered Intravenously Prior to,  and Intracranially at the Time of,  Subsequent Resection for Recurrent High Grade Glioma and Followed

by Treatment with Toca FC, Extended?Release 5?FC

 

A Phase 3 Clinical Trial Evaluating DCVax-L, Autologous Dendritic Cell Pulsed with Tumor Lysate Antigen for the Treatment of Newly Diagnosed Glioblastoma. * This trial needs to be screened prior to resection as the vaccine is made from the patients own tumor tissue.

 

 

 

In addition, I am a Certified Provider of the Novo-TTF 100A Device for Recurrent Malignant Glioblastoma.  

 

Thank you for your help,

 

Joseph C. Landolfi, D.O.

Chief of Neurology

JFK Neuroscience

Director of Neuro-oncology

Medical Director, Gamma Knife Program

JFK Brain Tumor Center

Chairman, Institutional Review Board

JFK Health

 

Medical Director of Neuro-oncology

Meridian Health

 

Professor of Neurology

Seton Hall School of Health and Medical Sciences

 

732-321-7950-office phone

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740